Paragonix initiates GUARDIAN-HEART study in paediatric patients

By NS Medical Staff Writer

29 Jul 21

The paediatric registry collects real-world data and determines the impact of advanced preservation methods compared to standard methods

DevicesCardiovascular

Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring

By NS Medical Staff Writer

29 Jul 21

AI Algorithms Enhance LINQ II™ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients

DevicesCardiovascular

CorMatrix Cardiovascular completes growth financing led by Jam Capital Partners

By NS Medical Staff Writer

28 Jul 21

Leading Developer of Regenerative Cardiovascular Products to Complete FDA Clinical Trial and Advance Other Technologies in Treatment of…

DevicesCardiovascular

Boston Scientific’s WATCHMAN FLX LAAC device meets 24-month endpoint in study

By NS Medical Staff Writer

22 Jul 21

The trial is designed to assess the safety and efficacy of the next-generation WATCHMAN FLX LAAC device to…

DevicesCardiovascular

Ancora Heart wins $80m funding for AccuCinch ventricular restoration system trial

By NS Medical Staff Writer

20 Jul 21

The randomised and international clinical trial will enroll around 400 patients at up to 80 centres across the…

DevicesCardiovascular

CARMAT achieves first commercial implant of artificial heart in Italy

By NS Medical Staff Writer

19 Jul 21

The company received CE marking for its artificial heart as a bridge to transplant in December last year

DevicesCardiovascular

CORCYM enrolls first patient in MANTRA Study

By NS Medical Staff Writer

19 Jul 21

The first patient was implanted in Italy, at Città di Lecce Hospital with a Bicarbon aortic mechanical valve

DevicesCardiovascular

HeartFlow to merge with Longview Acquisition in $2.8bn deal

By NS Medical Staff Writer

16 Jul 21

The combined entity will operate as HeartFlow Group with an estimated $400m in cash

DevicesCardiovascular

Imperative Care raises $260m funding to advance stroke care

By NS Medical Staff Writer

16 Jul 21

The company has also acquired peripheral thrombectomy company Truvic Medical, in a stock-for-stock transaction

DevicesCardiovascular

First Five Patients Successfully Treated with atHeart Medical’s Novel reSept Atrial Septal Defect Occluder in US IDE Pivotal Trial

By NS Medical Staff Writer

15 Jul 21

The first occluder with a metal-free, bioresorbable frame for the treatment of patients with clinically significant, isolated ASDs

DevicesCardiovascular